Author:
Zhang Bing,Li Ya,Peng Aihong,Liu Cuiyi,Lin Jiesheng,Feng Yujia,Wan Jing
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Global regional. National incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–59.
2. Tsai TT, Stanislawski MA, Shunk KA, Armstrong EJ, Grunwald GK, Schob AH, Valle JA, Alfonso CE, Nallamothu BK, Ho PM, et al. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Interventions. 2017;10(9):866–75.
3. Elias J, Hoebers LPC, van Dongen IM, Claessen BEPM, Henriques JPS. Impact of collateral circulation on survival in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with a concomitant chronic total occlusion. JACC: Cardiovasc Interventions. 2017;10(9):906–14.
4. Masahiko H, Yasuhiko S, Daisaku N, Shinichiro S, Masami N, Hiroshi S, Tetsuhisa K, Shinsuke N, Masatsugu H, Issei K. Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study. BMJ Open. 2016;6(7):e011105.
5. Kurtul A, Duran M. The correlation between lymphocyte/monocyte ratio and coronary collateral circulation in stable coronary artery disease patients. Biomark Med. 2017;11(1):43–52.